HCW Biologics Inc (HCWB) Financials

$3.36

$-0.10 (-2.75%)

As on 02-Sep-2026 16:22EDT

Market cap

$6 Mln

Revenue (TTM)

$7 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	6.72	0.05	2.57	2.84	6.72	4.10
Cost of Revenue	0.27	0.04	1.61	2.28	4.14	0.54
Gross Profit	6.45	0.01	0.96	0.56	2.59	-0.54
Operating Expenses	12.59	11.27	30.44	26.28	17.67	13.37
Operating Profit (EBIT)	-6.15	-11.26	-29.48	-25.72	-15.08	-13.37
Other Income	--	--	--	--	--	--
Profit before Tax	-5.23	-7.96	-30.02	-24.99	-14.90	-12.86
Provision for Tax	9.82	--	--	0.00	-0.18	-0.51
Profit after Tax (Net Income)	-4.92	-7.96	-30.02	-24.99	-14.90	-12.86
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-14.90	-12.86

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	7.43	2.76	-6.77	13.46	37.43	51.19
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.69	0.69	7.38	6.30	6.42	0.22
Current Liabilities	18.65	21.06	29.63	8.75	2.96	2.32
Total Liabilities	45.42	24.52	30.24	28.51	46.81	53.51

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	25.63	22.24	24.54	22.11	12.74	13.03
Current Assets	1.14	2.28	5.70	6.40	34.07	40.48
Total Assets	27.91	24.52	30.24	28.51	46.81	53.51
Total Debt*	6.56	6.81	13.69	6.30	6.41	--
Net Current Assets	--	-18.78	-23.93	-2.34	31.11	38.16

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-13.39	-14.23	-22.51	-10.39	-10.98
Cash Flow from Investing Activities	--	--	-0.26	3.80	14.71	-35.02
Cash from Financing Activities	--	10.67	15.57	-0.01	6.27	49.27
Net Cash Inflow / Outflow	--	--	--	--	10.60	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-13.14	-22.77	-4.64	-0.69	-2.49	-2.61
Cash EPS ($)	--	-19.79	-4.46	-0.66	-2.37	-2.50
Adjusted Book Value ($)	--	7.91	--	0.37	6.26	10.39
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-38.31	-2.20	-0.62	-1.74	-2.23
Free Cash Flow per Share ($)	--	-38.31	-2.24	-0.80	-3.46	-2.24

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-96.50	-225.00	-78.59	-31.36	-38.88
ROE (%)	-96.57	397.45	-897.37	-98.23	-33.63	-39.22
ROA (%)	-11.76	-29.07	-102.21	-66.37	-29.71	-37.33
EBIT Margin (%)	-72.49	-12,371.73	-1,124.57	-869.56	-219.78	-313.74
Net Margin (%)	-73.22	-14,677.14	-1,169.70	-879.52	-221.67	-313.74
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	707.02	-0.98	-0.10	-0.58	0.64	--
EBIT Growth (%)	48.94	76.76	-16.81	-67.26	-14.86	-120.83
Net Profit Growth (%)	56.83	73.49	-20.12	-67.74	-15.85	-122.54
EPS Growth (%)	-65.64	-3.90	-5.69	0.72	0.04	-1.15
Book Value Growth (%)	12,229.02	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.04	-0.10	-1.77	-0.77	-0.89
Price / Book Value	0.78	0.12	-0.43	3.28	0.31	0.22
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.63	-0.92	-0.43	-1.99	1.01	2.05
Close Price ($)	4.99	5.82	107.06	294.00	459.55	556.80
High Price ($)	44.10	247.20	604.80	556.80	796.80	1,866.00
Low Price ($)	1.50	5.72	66.26	218.40	422.40	554.40
Market Cap ($ Cr)	6.30	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	2.46	-2.02	0.47	0.17	--
Short term debt to equity ratio	0.88	2.46	-0.93	0.00	0.17	0.04
Current Ratio	0.06	0.11	0.19	0.73	11.52	17.44
Quick Ratio	0.06	--	--	--	11.05	16.49
Interest Coverage	-8.04	-5.37	-24.92	-87.31	-116.64	-25.45

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	0.27	59.33	22.68	54.04	6.21	3.24
Asset Turnover	0.16	0.00	0.09	0.08	0.13	0.12
Receivable days	--	2,068.90	150.69	125.54	14.96	117.29
Inventory Days	--	--	--	223.32	158.59	918.79
Payable days	--	149,327.93	3,238.00	591.83	64.02	127.33
Cash Conversion Cycle	--	--	--	-242.97	109.53	908.75

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.